PRGO
Perrigo Company PLC
NYSE: PRGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$11.29
-1.91% today
Updated 2026-04-29
Market cap
$1.55B
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-10.12
Dividend yield
10.10%
52W range
$9 – $27
Volume
3.5M
Perrigo Company PLC (PRGO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-33.50%
Operating margin
10.20%
ROE
-38.70%
ROA
2.35%
Debt/equity
0.86x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.45B | $73.80M | 27.75% | 6.81% | 5.10% |
| 2007 | $1.82B | $135.77M | 30.24% | 10.84% | 7.45% |
| 2008 | $2.01B | $144.05M | 29.70% | 12.32% | 7.18% |
| 2009 | $2.27B | $222.55M | 32.88% | 14.80% | 9.81% |
| 2010 | $2.76B | $339.20M | 34.30% | 17.79% | 12.31% |
| 2011 | $3.17B | $401.61M | 34.53% | 17.94% | 12.66% |
| 2012 | $3.54B | $441.90M | 36.16% | 19.18% | 12.48% |
| 2013 | $4.06B | $205.30M | 35.65% | 9.88% | 5.06% |
| 2014 | $4.06B | $205.30M | 35.65% | 13.96% | 5.06% |
| 2015 | $4.60B | $127.90M | 37.19% | 16.24% | 2.78% |
| 2016 | $5.28B | $-4.01B | 38.86% | -37.87% | -75.99% |
| 2017 | $4.95B | $119.60M | 40.02% | 12.09% | 2.42% |
| 2018 | $4.73B | $131.00M | 38.71% | 5.00% | 2.77% |
| 2019 | $3.87B | $146.10M | 37.05% | 4.51% | 3.78% |
| 2020 | $4.09B | $-162.60M | 36.57% | 6.49% | -3.98% |
| 2021 | $4.14B | $-68.90M | 34.22% | 9.92% | -1.66% |
| 2022 | $4.45B | $-140.60M | 32.69% | 1.77% | -3.16% |
| 2023 | $4.66B | $-12.70M | 36.09% | 3.26% | -0.27% |
| 2024 | $4.37B | $-171.80M | 35.27% | 2.58% | -3.93% |
| 2025 | $4.25B | $-1.43B | 35.14% | 8.07% | -33.51% |